CIK 0001404281
- Non-accelerated filer
- Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-31 | Perrin Steven President | Grant or award | +152,353 | 153,353 | ||
| 2026-07-31 | Perrin Steven President | Shares withheld for taxes | −72,138 | $3.38 | $244K | 81,215 |
| 2025-01-10 | Perrin Steven President | Grant or award · Stock Option (right to buy) | +243,000 | 243,000 | ||
| 2025-01-10 | Perrin Steven President | Grant or award · Restricted Stock Units | +27,000 | 27,000 | ||
| 2024-11-21 | Perrin Steven President | Grant or award · Stock Option (right to buy) | +840,438 | 840,438 | ||
| 2024-06-13 | Perrin Steven President | Grant or award · Stock Option (right to buy) | +428,148 | 428,148 | ||
| 2023-05-01 | Perrin Steven President | Grant or award · Stock Option (right to buy) | +317,147 | 317,147 | ||
| 2023-02-01 | Perrin Steven President | Grant or award · Stock Option (right to buy) | +155,000 | 155,000 | ||
| 2022-11-23 | Perrin Steven President | Purchase | +1,000 | $2.60 | $3K | 1,000 |
| 2022-02-01 | Perrin Steven President | Grant or award · Stock Option (right to buy) | +155,000 | 155,000 |
Page 1 of 1 · 10 trades